Current Update on Transcellular Brain Drug Delivery

Pharmaceutics. 2022 Dec 5;14(12):2719. doi: 10.3390/pharmaceutics14122719.

Abstract

It is well known that the presence of a blood-brain barrier (BBB) makes drug delivery to the brain more challenging. There are various mechanistic routes through which therapeutic molecules travel and deliver the drug across the BBB. Among all the routes, the transcellular route is widely explored to deliver therapeutics. Advances in nanotechnology have encouraged scientists to develop novel formulations for brain drug delivery. In this article, we have broadly discussed the BBB as a limitation for brain drug delivery and ways to solve it using novel techniques such as nanomedicine, nose-to-brain drug delivery, and peptide as a drug delivery carrier. In addition, the article will help to understand the different factors governing the permeability of the BBB, as well as various formulation-related factors and the body clearance of the drug delivered into the brain.

Keywords: blood–brain barrier; exosome; nanocarriers; nose-to-brain delivery; peptide; transcytosis.

Publication types

  • Review

Grants and funding

The authors would also like to acknowledge the Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers, India, for supporting research on cancer-targeted nanomedicine at NIPER- Ahmedabad. RKT would like to acknowledge the Science and Engineering Research Board (Statutory Body Established through an Act of Parliament: SERB Act 2008), Department of Science and Technology, Government of India for a grant (Grant no. ECR/2016/001964) and Core Research Grant funding (File Number: CRG/2021/005402) in Tekade’s Laboratory. RKT would also like to acknowledge the Indian Council of Medical Research (ICMR), New Delhi, for grant File Id: 2021-14161 for research work on diabetic wound healing.